Herd immunity to GII.4 noroviruses is supported by outbreak patient sera
about
Norovirus immunity and the great escapeImmunogenetic mechanisms driving norovirus GII.4 antigenic variationExperimental inoculation of juvenile rhesus macaques with primate enteric calicivirusesPathogenesis of noroviruses, emerging RNA virusesHuman Sera Collected between 1979 and 2010 Possess Blocking-Antibody Titers to Pandemic GII.4 Noroviruses Isolated over Three Decades.Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002.Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes.Fitting outbreak models to data from many small norovirus outbreaks.The impact of environmental and climatic variation on the spatiotemporal trends of hospitalized pediatric diarrhea in Ho Chi Minh City, Vietnam.Molecular epidemiology of genogroup II-genotype 4 noroviruses in the United States between 1994 and 2006Identification of cross-reactive norovirus CD4+ T cell epitopesHeterotypic humoral and cellular immune responses following Norwalk virus infection.Within-host evolution results in antigenically distinct GII.4 norovirusesDivergent evolution of norovirus GII/4 by genome recombination from May 2006 to February 2009 in Japan.Particle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope.Genetic and phenotypic characterization of GII-4 noroviruses that circulated during 1987 to 2008.Serological correlate of protection against norovirus-induced gastroenteritisSusceptibility to winter vomiting disease: a sweet matter.Norovirus GII.4 strain antigenic variationAffinities of recombinant norovirus P dimers for human blood group antigensComparison of age-stratified seroprevalence of antibodies against norovirus GII in India and the United KingdomIsolation of cross-reactive human monoclonal antibodies that prevent binding of human noroviruses to histo-blood group antigens.Identification of immune and viral correlates of norovirus protective immunity through comparative study of intra-cluster norovirus strains.Experimental human infection with Norwalk virus elicits a surrogate neutralizing antibody response with cross-genogroup activityQualitative and quantitative analysis of the binding of GII.4 norovirus variants onto human blood group antigens.Norovirus-host interaction: multi-selections by human histo-blood group antigens.Comparative evolution of GII.3 and GII.4 norovirus over a 31-year periodBroad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trialGenetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity.Immunogenicity and specificity of norovirus Consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations.Novel GII.12 norovirus strain, United States, 2009-2010.The importance of intergenic recombination in norovirus GII.3 evolutionCharacterization of blockade antibody responses in GII.2.1976 Snow Mountain virus-infected subjects.Norovirus virus-like particle vaccines for the prevention of acute gastroenteritis.Progress toward norovirus vaccines: considerations for further development and implementation in potential target populations.Deep sequencing of norovirus genomes defines evolutionary patterns in an urban tropical settingSeroprevalence in Household Raised Pigs Indicate High Exposure to GII Noroviruses in Rural Nicaragua.Surveillance of norovirus among children with diarrhea in four major hospitals in Bhutan: Replacement of GII.21 by GII.3 as a dominant genotype.Assessment of Functional Norovirus Antibody Responses by Blocking Assay in Mice.Norovirus infections and seroprevalence of genotype GII.4-specific antibodies in a Spanish population.
P2860
Q21090486-86601DCF-C3A2-4344-9812-D4E04307128CQ24810360-DF8DCF56-8841-4D51-89D4-CF7843E36EB9Q27302049-C645C711-1525-4A2D-AAD7-C8539A93406BQ28392368-F74C9CAC-DF3F-40AC-A8CE-DCF7BC71532AQ30401642-4746AD26-E1DA-47E3-85F7-A0F91B74326DQ30409563-D5DC6873-2D52-4763-9C9C-ABABFF01E8EBQ30425145-6BBCD01A-5F98-41FC-891D-B050BE7B2A94Q30769890-5C02003D-8ECC-4942-95F9-F28C9E9E7361Q30996836-B110A7D0-DC47-4FEC-B88A-027486FA4CF0Q33614256-C505AE04-D09F-41D4-A240-0E5D8E088692Q33614545-3016B7BA-A239-41FD-9D4D-C379D8507F6AQ33614589-41A24D25-2B9F-42B2-A94E-A493513CC83CQ33744124-DE108449-AAF8-4FC6-B80F-FEB79D5D4051Q34046026-67A51010-5ED2-45A9-B30B-E69D08E2D587Q34059136-C268ABAF-9EAB-479B-BCF6-1D043C57A55DQ34120230-67031DAC-A8A5-4302-9EC9-1A2397DC261DQ34153875-25A11E31-09DE-4AB1-8E26-3957E16C7370Q34227237-405426B1-C4DD-47EB-8166-C9937A57F909Q34457831-E9BE8866-DE2B-4D05-BA7C-333CBAC264D7Q34464196-99198C24-977B-42F1-BF53-3F7296B81EE9Q34598472-3AB739D4-CF17-40F3-8B52-16942B6ADE2AQ34985473-D26FCFE6-130F-4AAD-B882-B52BCF1D66A8Q34987998-B4352D00-E9EA-4C8C-8011-811FEE950B7CQ35021149-44940C22-DF79-4F61-8015-1FA9C8B05AD5Q35076817-6B5C87DB-9860-4210-A5F3-BEE9D541621AQ35146233-7CFCBC91-F544-479F-AB14-529221111643Q35192903-50E73DCF-C4B9-462E-B4EF-3DB48CE123A0Q35212408-27282FBE-8B8F-42F7-B9C8-C4FD3240E2A7Q35665784-048B432D-BDCD-45DA-A34A-021FCB3935F0Q35983587-3281818D-EAC6-433F-AE52-B83D9D14D5E4Q36053705-4083237D-BB7E-45FE-8ED6-40FDC5D6DF3FQ36759705-71D11F50-73ED-4EAF-9C05-F45B3C30CA09Q37547547-C21E6212-33A8-4696-A559-C73BB275EC39Q38081967-9A7B03EF-1FC3-4074-BAE6-A096EEC320C4Q38557262-5EAD3281-983D-4D24-84A8-D7C63307FF3DQ38954444-F76EFCAB-D151-4181-B7D7-279A920C01E4Q39770349-5059D35D-F789-4BDE-875A-C2EEFBC13EA4Q40046249-FA3796F6-AC84-4C66-9EF7-4AF0032E979AQ40715789-8520DC32-2040-4FA5-996C-15446AF95BFEQ41500656-AF49B234-D6A9-45CE-874A-A348B1D3C1B5
P2860
Herd immunity to GII.4 noroviruses is supported by outbreak patient sera
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Herd immunity to GII.4 noroviruses is supported by outbreak patient sera
@ast
Herd immunity to GII.4 noroviruses is supported by outbreak patient sera
@en
type
label
Herd immunity to GII.4 noroviruses is supported by outbreak patient sera
@ast
Herd immunity to GII.4 noroviruses is supported by outbreak patient sera
@en
prefLabel
Herd immunity to GII.4 noroviruses is supported by outbreak patient sera
@ast
Herd immunity to GII.4 noroviruses is supported by outbreak patient sera
@en
P2093
P2860
P921
P356
P1433
P1476
Herd immunity to GII.4 noroviruses is supported by outbreak patient sera
@en
P2093
Eric F Donaldson
Jennifer L Cannon
Lauryn Saxe
Lisa C Lindesmith
P2860
P304
P356
10.1128/JVI.02518-08
P577
2009-03-18T00:00:00Z